$NXTC NextCure, Inc. Insider Trading Week 19/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NextCure, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NextCure, Inc. in week 19/2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 15 2019 | NXTC | NextCure, Inc. | Sofinnova Venture Partners IX, ... | 10% Owner | Option Exercise | C | 0.00 | 3,773,585 | 0 | 0 | |
May 15 2019 | NXTC | NextCure, Inc. | Sofinnova Venture Partners IX, ... | 10% Owner | Option Exercise | C | 0.00 | 7,301,000 | 0 | 0 | |
May 15 2019 | NXTC | NextCure, Inc. | Sofinnova Venture Partners IX, ... | 10% Owner | Option Exercise | C | 0.00 | 3,732,500 | 0 | 0 | |
May 15 2019 | NXTC | NextCure, Inc. | Sofinnova Venture Partners IX, ... | 10% Owner | Option Exercise | C | 0.00 | 2,239,500 | 0 | 0 | |
May 15 2019 | NXTC | NextCure, Inc. | Sofinnova Venture Partners IX, ... | 10% Owner | Buy | P | 15.00 | 400,000 | 6,000,000 | 2,521,856 | 2.1 M to 2.5 M (+18.85 %) |
May 15 2019 | NXTC | NextCure, Inc. | Sofinnova Venture Partners IX, ... | 10% Owner | Buy | C | 0.00 | 469,713 | 0 | 2,121,856 | 1.7 M to 2.1 M (+28.43 %) |
May 15 2019 | NXTC | NextCure, Inc. | Sofinnova Venture Partners IX, ... | 10% Owner | Buy | C | 0.00 | 908,785 | 0 | 1,652,143 | 743.4 K to 1.7 M (+122.25 %) |
May 15 2019 | NXTC | NextCure, Inc. | Sofinnova Venture Partners IX, ... | 10% Owner | Buy | C | 0.00 | 464,599 | 0 | 743,358 | 278.8 K to 743.4 K (+166.67 %) |
May 15 2019 | NXTC | NextCure, Inc. | Sofinnova Venture Partners IX, ... | 10% Owner | Buy | C | 0.00 | 278,759 | 0 | 278,759 | 0 to 278.8 K |
May 13 2019 | NXTC | NextCure, Inc. | Alexandria Venture Investments ... | 10% Owner | Option Exercise | C | 0.00 | 628,931 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | Alexandria Venture Investments ... | 10% Owner | Option Exercise | C | 0.00 | 365,727 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | Alexandria Venture Investments ... | 10% Owner | Option Exercise | C | 0.00 | 372,500 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | Alexandria Venture Investments ... | 10% Owner | Option Exercise | C | 0.00 | 223,500 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | Alexandria Venture Investments ... | 10% Owner | Buy | C | 0.00 | 197,993 | 0 | 197,993 | 0 to 198 K |
May 13 2019 | NXTC | NextCure, Inc. | SHANNON TIMOTHY M | Director | Option Exercise | C | 0.00 | 2,296,605 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | SHANNON TIMOTHY M | Director | Option Exercise | C | 0.00 | 5,861,455 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | SHANNON TIMOTHY M | Director | Option Exercise | C | 0.00 | 5,970,000 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | SHANNON TIMOTHY M | Director | Option Exercise | C | 0.00 | 3,582,000 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | SHANNON TIMOTHY M | Director | Buy | P | 15.00 | 50,000 | 750,000 | 2,254,442 | 2.2 M to 2.3 M (+2.27 %) |
May 13 2019 | NXTC | NextCure, Inc. | SHANNON TIMOTHY M | Director | Buy | C | 0.00 | 285,867 | 0 | 2,204,442 | 1.9 M to 2.2 M (+14.90 %) |
May 13 2019 | NXTC | NextCure, Inc. | SHANNON TIMOTHY M | Director | Buy | C | 0.00 | 729,599 | 0 | 1,918,575 | 1.2 M to 1.9 M (+61.36 %) |
May 13 2019 | NXTC | NextCure, Inc. | SHANNON TIMOTHY M | Director | Buy | C | 0.00 | 743,110 | 0 | 1,188,976 | 445.9 K to 1.2 M (+166.67 %) |
May 13 2019 | NXTC | NextCure, Inc. | SHANNON TIMOTHY M | Director | Buy | C | 0.00 | 445,866 | 0 | 445,866 | 0 to 445.9 K |
May 13 2019 | NXTC | NextCure, Inc. | Khuong Chau Quang | Director | Option Exercise | C | 0.00 | 3,554,466 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | Khuong Chau Quang | Director | Option Exercise | C | 0.00 | 5,861,455 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | Khuong Chau Quang | Director | Option Exercise | C | 0.00 | 5,970,000 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | Khuong Chau Quang | Director | Option Exercise | C | 0.00 | 3,582,000 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | Khuong Chau Quang | Director | Buy | P | 15.00 | 350,000 | 5,250,000 | 2,711,013 | 2.4 M to 2.7 M (+14.82 %) |
May 13 2019 | NXTC | NextCure, Inc. | Khuong Chau Quang | Director | Buy | C | 0.00 | 442,438 | 0 | 2,361,013 | 1.9 M to 2.4 M (+23.06 %) |
May 13 2019 | NXTC | NextCure, Inc. | Khuong Chau Quang | Director | Buy | C | 0.00 | 729,599 | 0 | 1,918,575 | 1.2 M to 1.9 M (+61.36 %) |
May 13 2019 | NXTC | NextCure, Inc. | Khuong Chau Quang | Director | Buy | C | 0.00 | 743,110 | 0 | 1,188,976 | 445.9 K to 1.2 M (+166.67 %) |
May 13 2019 | NXTC | NextCure, Inc. | Khuong Chau Quang | Director | Buy | C | 0.00 | 445,866 | 0 | 445,866 | 0 to 445.9 K |
May 13 2019 | NXTC | NextCure, Inc. | Xu Stella | Director | Option Exercise | C | 0.00 | 7,861,636 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | Xu Stella | Director | Buy | P | 15.00 | 125,000 | 1,875,000 | 1,103,570 | 978.6 K to 1.1 M (+12.77 %) |
May 13 2019 | NXTC | NextCure, Inc. | Xu Stella | Director | Buy | C | 0.00 | 978,570 | 0 | 978,570 | 0 to 978.6 K |
May 13 2019 | NXTC | NextCure, Inc. | CANAAN X L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,296,605 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | CANAAN X L.P. | 10% Owner | Option Exercise | C | 0.00 | 5,861,455 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | CANAAN X L.P. | 10% Owner | Option Exercise | C | 0.00 | 5,970,000 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | CANAAN X L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,582,000 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | CANAAN X L.P. | 10% Owner | Buy | P | 15.00 | 50,000 | 750,000 | 2,254,442 | 2.2 M to 2.3 M (+2.27 %) |
May 13 2019 | NXTC | NextCure, Inc. | CANAAN X L.P. | 10% Owner | Buy | C | 0.00 | 285,867 | 0 | 2,204,442 | 1.9 M to 2.2 M (+14.90 %) |
May 13 2019 | NXTC | NextCure, Inc. | CANAAN X L.P. | 10% Owner | Buy | C | 0.00 | 729,599 | 0 | 1,918,575 | 1.2 M to 1.9 M (+61.36 %) |
May 13 2019 | NXTC | NextCure, Inc. | CANAAN X L.P. | 10% Owner | Buy | C | 0.00 | 743,110 | 0 | 1,188,976 | 445.9 K to 1.2 M (+166.67 %) |
May 13 2019 | NXTC | NextCure, Inc. | CANAAN X L.P. | 10% Owner | Buy | C | 0.00 | 445,866 | 0 | 445,866 | 0 to 445.9 K |
May 13 2019 | NXTC | NextCure, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 3,554,466 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 5,861,455 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 5,970,000 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 3,582,000 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 15.00 | 350,000 | 5,250,000 | 2,711,013 | 2.4 M to 2.7 M (+14.82 %) |
May 13 2019 | NXTC | NextCure, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 442,438 | 0 | 2,361,013 | 1.9 M to 2.4 M (+23.06 %) |
May 13 2019 | NXTC | NextCure, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 729,599 | 0 | 1,918,575 | 1.2 M to 1.9 M (+61.36 %) |
May 13 2019 | NXTC | NextCure, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 743,110 | 0 | 1,188,976 | 445.9 K to 1.2 M (+166.67 %) |
May 13 2019 | NXTC | NextCure, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 445,866 | 0 | 445,866 | 0 to 445.9 K |